Cargando…

p-Cymene Complexes of Ruthenium(II) as Antitumor Agents

In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η(6)-p-cymene)RuCl(2)L] (I-VI), L = 4-cyanopyridine (I), 2-aminophenol (II), 4-aminophenol (III), pyridazine (IV), and [(η(6)-p-cymene)RuClL(2)]PF(6); L = cyanopyridine (V), L = 2-aminophenol(VI) towards three cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pujante-Galián, María Angeles, Pérez, Sergio A., Montalbán, Mercedes G., Carissimi, Guzmán, Fuster, Marta G., Víllora, Gloria, García, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662397/ https://www.ncbi.nlm.nih.gov/pubmed/33142775 http://dx.doi.org/10.3390/molecules25215063

Ejemplares similares

Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(p-Cymene)Cl(2)L] and Their Cytotoxicity against HeLa-Type Cancer Cells
por: Fuster, Marta G., et al.
Publicado: (2022)

Antitumor Activity of Rosmarinic Acid-Loaded Silk Fibroin Nanoparticles on HeLa and MCF-7 Cells
por: Fuster, Marta G., et al.
Publicado: (2021)

Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
por: Fuster, Marta G., et al.
Publicado: (2020)

Direct Quantification of Drug Loading Content in Polymeric Nanoparticles by Infrared Spectroscopy
por: Carissimi, Guzmán, et al.
Publicado: (2020)

Accelerated Simple Preparation of Curcumin-Loaded Silk Fibroin/Hyaluronic Acid Hydrogels for Biomedical Applications
por: Chaala, Mohamed, et al.
Publicado: (2023)

On the Secondary Structure of Silk Fibroin Nanoparticles Obtained Using Ionic Liquids: An Infrared Spectroscopy Study
por: Carissimi, Guzmán, et al.
Publicado: (2020)

Dichlorido(η(6)-p-cymene)(4-fluoroaniline-κN)ruthenium(II)
por: Sykora, Richard E., et al.
Publicado: (2010)

Dichlorido(η(6)-p-cymene)(ethoxydiphenylphosphane)ruthenium(II)
por: Knapp, Spring M. M., et al.
Publicado: (2012)

Revealing the Influence of the Degumming Process in the Properties of Silk Fibroin Nanoparticles
por: Carissimi, Guzmán, et al.
Publicado: (2019)

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (Poly)cyclic Aromatic Diamine Ligands
por: Alsaeedi, Mona S., et al.
Publicado: (2020)

(η(6)-p-Cymene)bis(trichloridostannyl)(triethoxyphosphine-κP)ruthenium(II)
por: Shapovalov, Sergey S., et al.
Publicado: (2009)

Facile Arene Ligand Exchange in p-Cymene Ruthenium(II) Complexes of Tertiary P-Chiral Ferrocenyl Phosphines
por: Popp, John, et al.
Publicado: (2019)

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer
por: Domínguez-Jurado, Elena, et al.
Publicado: (2021)

Synthesis, Characterization, and Cytotoxicity Studies of N-(4-Methoxybenzyl) Thiosemicarbazone Derivatives and Their Ruthenium(II)-p-cymene Complexes
por: Martínez-Estévez, Mónica, et al.
Publicado: (2022)

Folic Acid-Modified Ibrutinib-Loaded Silk Fibroin Nanoparticles for Cancer Cell Therapy with Over-Expressed Folate Receptor
por: Fuster, Marta G., et al.
Publicado: (2023)

Synthesis of Cellulose Nanoparticles from Ionic Liquid Solutions for Biomedical Applications
por: Fuster, Marta G., et al.
Publicado: (2023)

Dichlorido(η(6)-p-cymene)[tris(4-methoxyphenyl)phosphane]ruthenium(II)
por: Davis, Wade L., et al.
Publicado: (2021)

New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents
por: de Melo, Ariane C.C., et al.
Publicado: (2019)

Physicochemical Studies and Anticancer Potency of Ruthenium η(6)-p-Cymene Complexes Containing Antibacterial Quinolones
por: Kljun, Jakob, et al.
Publicado: (2011)

Crystal structure of [3-amino-2-(phenyldiazenyl)pyridine]chlorido(η(6)-p-cymene)ruthenium(II) chloride
por: Hansongnern, Kanidtha, et al.
Publicado: (2015)

μ-Pyrazine-2,5-dicarboxylato-bis[chlorido(η(6)-p-cymene)ruthenium(II)] tert-butanol disolvate
por: Sanchez Ballester, Noelia M., et al.
Publicado: (2008)

Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group
por: Mokesch, Stephan, et al.
Publicado: (2019)

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
por: Adhireksan, Zenita, et al.
Publicado: (2014)

Combination of ruthenium(II)-arene complex [Ru(η(6)-p-cymene)Cl(2)(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
por: Berndsen, Robert H., et al.
Publicado: (2017)

Anticancer and antimicrobial properties of novel η(6)-p-cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization
por: Namiecińska, Ewelina, et al.
Publicado: (2019)

NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells
por: Garufi, Alessia, et al.
Publicado: (2023)

Update on Monoterpenes as Antimicrobial Agents: A Particular Focus on p-Cymene
por: Marchese, Anna, et al.
Publicado: (2017)

The Effect of Sterilization on the Characteristics of Silk Fibroin Nanoparticles
por: Asensio Ruiz, María Alejandra, et al.
Publicado: (2022)

Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds
por: Sunder A, Shyam, et al.
Publicado: (2013)

Tetraethylammonium trichlorido(η(6)-p-cymene)ruthenate(II)
por: Wu, Fang-Hui, et al.
Publicado: (2009)

Density and refractive index data of binary and ternary mixtures of imidazolium-based ionic liquids, n-hexane and organic compounds involved in the kinetic resolution of rac-2-pentanol
por: Montalbán, Mercedes G., et al.
Publicado: (2018)

Effects of Hypoxia and Transferrin on Toxicity and DNA Binding of Ruthenium Antitumor Agents in Hela Cells
por: Frasca, D., et al.
Publicado: (1996)

Antibacterial Effect of Chitosan–Gold Nanoparticles and Computational Modeling of the Interaction between Chitosan and a Lipid Bilayer Model
por: Fuster, M. G., et al.
Publicado: (2020)

(η(6)-p-Cymene)(1,3-dimesityl-2,3-dihydro-1H-imidazol-2-ylidene)bis(pentafluorobenzoato-κO)ruthenium(II) dichloromethane disolvate
por: Dorst, Konstantin, et al.
Publicado: (2012)

Production of Curcumin-Loaded Silk Fibroin Nanoparticles for Cancer Therapy
por: Montalbán, Mercedes G., et al.
Publicado: (2018)

[(1R)-3-Benzoyl-1,7,7-trimethylbicyclo[2.2.1]heptan-2-onato-κ(2) O,O′]chlorido(η(6)-p-cymene)ruthenium(II)
por: Harrad, Mohamed Anouar, et al.
Publicado: (2010)

Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes
por: Oberhuber, Natalie, et al.
Publicado: (2023)

(2,2′-Bipyridyl)(η(6)-p-cymene)iodidoruthenium(II) hexafluoridophosphate
por: Kelani, Monsuru T., et al.
Publicado: (2023)

Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity
por: Demoro, Bruno, et al.
Publicado: (2019)

Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo
por: Savic, Maja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_njctn2aal99tffjgjqpjoe71eu